These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6891959)

  • 1. Assessment of pointer dog behavior. Drug effects and neurochemical correlates.
    Angel C; DeLuca DC; Newton JE; Reese WG
    Pavlov J Biol Sci; 1982; 17(2):84-8. PubMed ID: 6891959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of chlordiazepoxide, amphetamine and cocaine on bar-press behavior in normal and genetically nervous dogs.
    Angel C; Murphree OD; DeLuca DC
    Dis Nerv Syst; 1974 May; 35(5):220-3. PubMed ID: 17894105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of perinatal chlordiazepoxide exposure on rat preweaning and postweaning behavior.
    Adams PM
    Neurobehav Toxicol Teratol; 1982; 4(3):279-82. PubMed ID: 7099344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chlordiazepoxide, buspirone and cocaine on behavior suppressed by timeout presentation.
    van Haaren F; Anderson KG
    Behav Pharmacol; 1997 Jun; 8(2-3):174-82. PubMed ID: 9833012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a benzodiazepine receptor agonist and corticotropin-releasing hormone receptor antagonists on long-term foot-shock-induced increase in defensive withdrawal behavior.
    Bruijnzeel AW; Stam R; Wiegant VM
    Psychopharmacology (Berl); 2001 Nov; 158(2):132-9. PubMed ID: 11702086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers.
    Brauer LH; de Wit H
    Biol Psychiatry; 1996 Jan; 39(1):26-32. PubMed ID: 8719123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers.
    Andreu N; Chalé JJ; Senard JM; Thalamas C; Montastruc JL; Rascol O
    Clin Neuropharmacol; 1999; 22(1):15-23. PubMed ID: 10047929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic-statistical analysis of environmental and genetic influences on the outcome of the juvenile and breeding performance tests for behaviour traits in Hovawart dogs].
    Boenigk K; Hamann H; Distl O
    Berl Munch Tierarztl Wochenschr; 2006; 119(5-6):258-69. PubMed ID: 16729474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.
    Nutt JG; Carter JH; Carlson NE
    Arch Neurol; 2007 Mar; 64(3):319-23. PubMed ID: 17353373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment.
    Frederick DL; Ali SF; Gillam MP; Gossett J; Slikker W; Paule MG
    Ann N Y Acad Sci; 1998 May; 844():183-90. PubMed ID: 9668676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy.
    Davis ID; Kiers L; MacGregor L; Quinn M; Arezzo J; Green M; Rosenthal M; Chia M; Michael M; Bartley P; Harrison L; Daly M
    Clin Cancer Res; 2005 Mar; 11(5):1890-8. PubMed ID: 15756015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chlordiazepoxide, 8-OH-DPAT and ondansetron on radiation-induced decreases in food intake in rats.
    Winsauer PJ; Verrees JF; O'Halloran KP; Bixler MA; Mele PC
    J Pharmacol Exp Ther; 1994 Jul; 270(1):142-9. PubMed ID: 8035310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of pimozide and thioridazine as antagonists of amphetamine-induced stereotyped behavior in dogs.
    Klingenstein RJ; Wallach MB; Gershon S
    Arch Int Pharmacodyn Ther; 1973 May; 203(1):67-71. PubMed ID: 4725340
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of clomipramine in the treatment of canine compulsive disorder.
    Hewson CJ; Luescher UA; Parent JM; Conlon PD; Ball RO
    J Am Vet Med Assoc; 1998 Dec; 213(12):1760-6. PubMed ID: 9861971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitation of avoidance behavior by chlordiazepoxide and chlordiazepoxide-amphetamine combination: effect on performance.
    Sansone M; Vetulani J
    Pol J Pharmacol Pharm; 1980; 32(2):125-31. PubMed ID: 7454619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-1B (PDE1B) enzyme.
    Siuciak JA; McCarthy SA; Chapin DS; Reed TM; Vorhees CV; Repaske DR
    Neuropharmacology; 2007 Jul; 53(1):113-24. PubMed ID: 17559891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and neurochemical effects on rat offspring after prenatal exposure to ethanol.
    Carneiro LM; Diógenes JP; Vasconcelos SM; Aragão GF; Noronha EC; Gomes PB; Viana GS
    Neurotoxicol Teratol; 2005; 27(4):585-92. PubMed ID: 16039829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.